Shoulder Innovations prices IPO of 5 million shares at $15.55 per share
Grand Rapids, Mich., July 30, 2025 /PRNewswire/ — Shoulder Innovations, Inc. ("Shoulder Innovations"), a commercial-stage medical technology company focused on transforming the shoulder surgical care market, has priced its initial public offering (IPO) of 5,000,000 shares of its common stock at $15.55 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Shoulder Innovations, are expected to be $77.75 million [1].
In addition to the initial offering, Shoulder Innovations has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the initial public offering price less underwriting discounts and commissions. The common stock is expected to begin trading on the New York Stock Exchange under the ticker symbol "SI" on July 31, 2025. The offering is expected to close on August 1, 2025, subject to satisfaction of customary closing conditions [1].
Morgan Stanley, Goldman Sachs & Co. LLC, and Piper Sandler are acting as joint lead book-running managers for the offering. Jefferies is also acting as book-running manager and BTIG is acting as lead manager for the offering. A registration statement on Form S-1 (File No. 333-288549) relating to the securities being sold in this offering was declared effective by the U.S. Securities and Exchange Commission on July 30, 2025 [1].
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. The company offers advanced implant systems for shoulder arthroplasty, which are a core element of its ecosystem designed to improve core components of shoulder surgical care – preoperative planning, implant design, and procedural efficiency – to benefit each stakeholder in the care chain [1].
References:
[1] https://www.prnewswire.com/news-releases/shoulder-innovations-announces-pricing-of-initial-public-offering-302518121.html
Comments
No comments yet